
Nautilus Biotechnology (NAUT) Stock Forecast & Price Target
Nautilus Biotechnology (NAUT) Analyst Ratings
Based on 4 analyst ratings
Hold
Strong Buy 25%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 25%
Nautilus Biotechnology (NAUT) has been analyzed by 4 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 25% predict a Strong Sell.
This aggregate rating is based on analysts' research of Nautilus Biotechnology and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Nautilus Biotechnology and is not a guaranteed prediction by Public.com or investment advice.
Nautilus Biotechnology (NAUT) Analyst Forecast & Price Prediction
Get the latest Nautilus Biotechnology (NAUT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Nautilus Biotechnology (NAUT)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Nautilus Biotechnology (NAUT) Forecast
Analysts have given Nautilus Biotechnology (NAUT) a Hold based on their latest research and market trends.
According to 4 analysts, Nautilus Biotechnology (NAUT) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $4.19, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $4.19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.